Fundraising Fox

Bobak Azamian, MD, PhD

Founder

Founder at Tarsus Pharmaceuticals

Irvine, California, United States

FoundedTarsus Pharmaceuticals

Find your path to Bobak

610 people in our graph share verified history with Bobak — schools, employers, funds. One of them is your warm intro.

Anthony PhilippakisunlockedBobak: together at Brigham and Women's Hospital (2009–2011)
Bobak: together at Harvard Medical School
×3Bobak: together at University of Oxford
×7Bobak: together at Third Rock Ventures

About

Bobak Azamian, MD, PhD, is Co-founder, Chairman, and CEO of Tarsus Pharmaceuticals, Inc., which he founded in 2016. Under his leadership, the company completed an IPO, raised approximately $800 million in financing, and in 2023 launched XDEMVY, an FDA-approved treatment for Demodex blepharitis. Tarsus is developing additional therapies for conditions including ocular rosacea and Lyme disease prevention.

Founder at Tarsus Pharmaceuticals

Intro paths

→

In turn, Bobak can intro founders to Tarsus Pharmaceuticals's investors below.

Tarsus Pharmaceuticals's investors · 8

APERTURE Venture PartnersBoston · $1M – $5M checksBain Capital Life SciencesBostonFlying L PartnersFrazier Life SciencesPalo AltoRTW Investments L.P.New YorkVisionary VentureAliso ViejoVisionary VenturesNewport Beach · $5M – $15M checksVivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Tarsus Pharmaceuticals

BABobak Azamian
Bobak AzamianPresident and Chief Executive Officer

President and Chief Executive Officer at Tarsus Pharmaceuticals

Intro paths

→

In turn, Bobak can intro founders to Tarsus Pharmaceuticals's investors below.

Tarsus Pharmaceuticals's investors · 8

APERTURE Venture PartnersBoston · $1M – $5M checksBain Capital Life SciencesBostonFlying L PartnersFrazier Life SciencesPalo AltoRTW Investments L.P.New YorkVisionary VentureAliso ViejoVisionary VenturesNewport Beach · $5M – $15M checksVivo CapitalPalo Alto · $10M – $50M checks

Co-founders at Tarsus Pharmaceuticals

BABobak Azamian, MD, PhD
Bobak Azamian, MD, PhDFounder

Experience

  1. Tarsus Pharmaceuticals, Inc.Chairmancurrent2022 — present
  2. Tarsus Pharmaceuticals, Inc.President and CEOcurrent2018 — present
  3. Vibrato Medical, Inc.Board Membercurrent2022 — present
  4. Vibrato Medical, Inc.Co-Chair2019 — 2022
  5. UCI Edwards Lifesciences Foundation, Cardiovascular Innovation and Research Center (CIRC)Leadership Council Membercurrent2012 — present
  6. Osanni BioChair of the Board2023 — 2026
  7. Octane OCBoard Member2012 — 2021
  8. Metavention, Inc.President and CMO2013 — 2018
  9. Versant VenturesInvestment Professional2011 — 2013
  10. Third Rock VenturesSenior Associate2009 — 2011
  11. Third Rock VenturesConsultant2007 — 2009
  12. Brigham and Women's HospitalAttending Hospitalist2009 — 2011
  13. Brigham and Women's HospitalResidency, Internal Medicine2006 — 2009
  14. AmgenConsultant2003

Skills & more

Biotechnology99Medical Devices99Healthcare39Molecular Biology5Start-ups25Corporate Development8Due Diligence6Research5R&D12Clinical Trials8Commercialization17Entrepreneurship11
+11 moreHealthcare Information TechnologyDrug DiscoveryDrug DevelopmentClinical ResearchInternal MedicineLife SciencesClinical DevelopmentBiopharmaceuticalsMicrosoft OfficeStrategic PlanningLeadership

From Bobak's professional profile.

Frequently asked questions

Who is Bobak Azamian, MD, PhD?
Bobak Azamian, MD, PhD, is Co-founder, Chairman, and CEO of Tarsus Pharmaceuticals, Inc., which he founded in 2016. Under his leadership, the company completed an IPO, raised approximately $800 million in financing, and in 2023 launched XDEMVY, an FDA-approved treatment for Demodex blepharitis. Tarsus is developing additional therapies for conditions including ocular rosacea and Lyme disease prevention.
Where does Bobak Azamian, MD, PhD work?
Bobak Azamian, MD, PhD is President and Chief Executive Officer of Tarsus Pharmaceuticals.
What companies did Bobak Azamian, MD, PhD found?
Bobak Azamian, MD, PhD founded Tarsus Pharmaceuticals.
Where did Bobak Azamian, MD, PhD go to school?
Bobak Azamian, MD, PhD studied at Harvard Medical School (Doctor of Medicine (MD)); University of Oxford (Doctor of Philosophy (PhD), Chemistry); Rice University (BA, Physics (Biophysics)).

Founder mafias

University of Oxford mafia622

Also came through, then founded or led a company.

Reid HoffmanM.St.Founded LinkedIn +2Gabriel PereyraDropped outFounded HarveyBrent HobermanMaster of Arts - MAFounded Founders Pledge +4Kevin HartzMstFounded Eventbrite +3William GuttmanM.PhilFounded CurvePoint +3Tom BlomfieldMaster's DegreeFounded Starling Bank +2

+ 615 more

Harvard Medical School mafia111

Also came through, then founded or led a company.

George ChurchFounded Editas Medicine +5Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Port Therapeutics +3Andrey ZarurClinical ImmunologyFounded GreenLight Pandemic Response +3Howard ChangM.D.Founded Accent Therapeutics +3Michael TolentinoResidencyFounded Aviceda Therapeutics +2Venky SoundararajanResearch Fellowship in GeneticsFounded nference +2

+ 104 more

Rice University mafia104

Also came through, then founded or led a company.

Brian ArmstrongMaster’s DegreeFounded Coinbase +1Chris GibsonBachelor of Science (B.S.)Founded Recursion (NASDAQ: RXRX) +2Dan WallaceBSMEFounded Versa Vascular +2Suman KhatiwadaPh.D.Founded Syzygy Plasmonics +2Eric M. ElfmanMBAFounded Onit +2Web SmithStudy: RussianFounded Mizzen+Main +1

+ 97 more

Third Rock Ventures mafia23

Also came through, then founded or led a company.

Christoph LengauerPartnerFounded Celsius Therapeutics +3Reid HuberPartnerFounded MOMA Therapeutics +2Alexis BorisyPartnerFounded Foundation Medicine +2Steve PaulVenture PartnerFounded Voyager Therapeutics, Inc. +1Philip ReillyVenture PartnerFounded Luna Genetics +1Uday KumarEntrepreneur-in-ResidenceFounded Element Science +1

+ 16 more

Versant Ventures mafia12

Also came through, then founded or led a company.

Peter EmtageVenture PartnerFounded Santa Ana +1Erik T. EngelsonVenture PartnerFounded Medina Medical +1Mike RosenbluthInvestment ProfessionalFounded Swing +1Rami HannoushVenture PartnerFounded Epi BiologicsBryan BergCBO-in-ResidenceFounded StandardcapBeckie RobertsonManaging DirectorFounded Egis

+ 5 more

Same school

Also attended Harvard Medical School283

Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 277 more

Also attended University of Oxford1,657

Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures

+ 1,651 more

Also attended Rice University232

Brian ArmstrongCo-founder & CEO of CoinbaseAbigail JohnsonPartner, Chief Operating Officer at Sapphire VenturesEdi DanalacheSenior Associate at Scale Venture PartnersJim BridenstineManaging Partner, Artemis Group at Cortado VenturesNicolette HoffmannSenior Associate at JMI EquityPatrick OkoraforDirector of Finance at Mercury Fund

+ 226 more

Shared employers

Also worked at Tarsus Pharmaceuticals, Inc.3

Bill HoffmanVenture Partner at Vensana CapitalAziz MottiwalaChief Commercial Officer at Tarsus PharmaceuticalsDianne WhitfieldChief Human Resources Officer at Tarsus Pharmaceuticals

Also worked at Vibrato Medical, Inc.1

Paul LaVioletteManaging Partner at SV Health Investors

Also worked at Octane OC7

Tim GuleriInvestor at Sierra VenturesEhsan SadriInvestor at Visionary VenturesSandra MillerVenture Partner at Fresco CapitalCarey RansomManaging Director at BankTech VenturesLaura BekenVenture Partner at MEDA VenturesDr. Ehsan SadriInvestment Committee at Visionary Ventures

+ 1 more

Also worked at Metavention, Inc.1

Kevin HykesVenture Partner at Vensana Capital